Dolby Laboratories

DLB Industrials Specialty Business Services

Dolby Laboratories' revenue for fiscal 2025 (year ended September 2025) was $1.3 billion, up 5.92% from fiscal 2024. In the quarter to June 2026, revenue fell 3.34%, EPS fell 37.5% and free cash flow grew 157.4%, each against the same quarter a year earlier. Dividend growth for ten consecutive years.

59.95 0.88 −1.45%
Market cap
$5.7B
P/E
25.2×
Fwd P/E
16.5×
Dividend yield
2.40%
F-score
6/9
Altman Z
9.17
Beneish M
−2.80
Dividend safety
85/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
5 6 5 6

+8 more TTM periods

ROE
8.69% 9.35% 9.40% 9.96%
ROA
7.12% 7.52% 7.57% 8.05%
ROIC
8.06% 8.08% 8.24% 9.01%
Return on Tangible Assets
16.52% 17.38% 16.80% 17.95%
Average Days of Receivables
76.85 104.64 101.71 89.58
Free Cash Flow per Share
3.83 2.78 4.05 4.49
Free Cash Flow
361.13 264.72 386.30 430.26
Other line items

Show all line items

Columns are period end dates